Fig. 4
From: Programmed ROS/CO-releasing nanomedicine for synergetic chemodynamic-gas therapy of cancer
The cytotoxicity of MSN, FeCO@MSN, MnO2@MSN and FeCO-MnO2@MSN against HeLa, B16 and 4T1 cells 24 h after incubation (a–c), mitochondrial imaging with red fluorescence (d), Comet assay of DNA damage of 4T1 cells after drug treatment (e), the ATP levels in 4T1 cells (f). Figures g and h are statistic results of Figures e and d, respectively. Mean value and error bar are defined as mean and s.d., respectively